Home » Psychology news » FDA Approves Saphris Tablets (asenapine) To Treat Schizophrenia And Bipolar Disorder

FDA Approves Saphris Tablets (asenapine) To Treat Schizophrenia And Bipolar Disorder

August 16, 2009 by

The U.S. Food and Drug Administration has approved Saphris tablets (asenapine) to treat adults with schizophrenia, a chronic, severe and disabling brain disorder, and to treat bipolar I disorder in adults, a serious psychiatric disorder that causes shifts in a person's mood, energy, and ability to function. "Mental illnesses like schizophrenia and bipolar disorder can be devastating to patients and families, requiring lifelong treatment and therapy," said Thomas Laughren, M.D.